Shares of Santarus Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, surged in trading on Friday after the company agreed to be acquired by Salix Pharmaceuticals Ltd. (NASDAQ: SXLP). The two companies entered into a definitive agreement under which SLXP will acquire all outstanding shares of Santarus for $32 per share in cash. The offer price [...]
Recent Comments